Skip to content

Healing Stigma Through Stories

Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07708402
Enrollment
24
Registered
2026-07-16
Start date
2026-08-01
Completion date
2027-07-01
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia / Schizoaffective Disorder

Keywords

schizophrenia, mix-method study, self-stigma, narrative therapy

Brief summary

This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia. A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.

Interventions

OTHERHealing Stigma through Stories

Four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma.

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years or older. * Diagnosed with schizophrenia or schizoaffective disorder. * Clinically stable at the time of study enrollment. * Able to communicate in Mandarin Chinese or Taiwanese. * Able to read and write and complete study questionnaires.

Exclusion criteria

* Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled. * Unwilling to have the intervention sessions audio-recorded.

Design outcomes

Primary

MeasureTime frame
The Internalized Stigma of Mental Illness ScaleAt baseline(T0) and through study completion, an average of 8 weeks

Secondary

MeasureTime frame
Beck Depression Inventory-IIAt baseline(T0) and through study completion, an average of 8 weeks
Self-Reported Graphic version of the Personal and Social Performance ScaleAt baseline(T0) and through study completion, an average of 8 weeks
Subjective Happiness ScaleAt baseline(T0) and through study completion, an average of 8 weeks
Herth Hope IndexAt baseline(T0) and through study completion, an average of 8 weeks
The questionnaire about the process of recoveryAt baseline(T0) and through study completion, an average of 8 weeks

Contacts

CONTACTLi-Ting Huang, phD
lthuang@nycu.edu.tw+8862-28267284

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026